Bristol Myers Squibb Stock Market Value
| BMY Stock | USD 58.78 0.09 0.15% |
| Symbol | Bristol |
Bristol Myers Squibb Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bristol Myers. If investors know Bristol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bristol Myers listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.36) | Dividend Share 2.4 | Earnings Share (3.58) | Revenue Per Share 23.41 | Quarterly Revenue Growth 0.084 |
The market value of Bristol Myers Squibb is measured differently than its book value, which is the value of Bristol that is recorded on the company's balance sheet. Investors also form their own opinion of Bristol Myers' value that differs from its market value or its book value, called intrinsic value, which is Bristol Myers' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bristol Myers' market value can be influenced by many factors that don't directly affect Bristol Myers' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bristol Myers' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bristol Myers is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bristol Myers' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Bristol Myers 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bristol Myers' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bristol Myers.
| 10/26/2024 |
| 11/25/2024 |
If you would invest 0.00 in Bristol Myers on October 26, 2024 and sell it all today you would earn a total of 0.00 from holding Bristol Myers Squibb or generate 0.0% return on investment in Bristol Myers over 30 days. Bristol Myers is related to or competes with Capricor Therapeutics, Soleno Therapeutics, Bio Path, Moleculin Biotech, Crinetics Pharmaceuticals, Assembly Biosciences, and Instil Bio. Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwi... More
Bristol Myers Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bristol Myers' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bristol Myers Squibb upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.49 | |||
| Information Ratio | 0.1151 | |||
| Maximum Drawdown | 14.39 | |||
| Value At Risk | (2.07) | |||
| Potential Upside | 2.23 |
Bristol Myers Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bristol Myers' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bristol Myers' standard deviation. In reality, there are many statistical measures that can use Bristol Myers historical prices to predict the future Bristol Myers' volatility.| Risk Adjusted Performance | 0.1454 | |||
| Jensen Alpha | 0.3339 | |||
| Total Risk Alpha | 0.0375 | |||
| Sortino Ratio | 0.1523 | |||
| Treynor Ratio | 3.11 |
Bristol Myers Squibb Backtested Returns
Bristol Myers appears to be very steady, given 3 months investment horizon. Bristol Myers Squibb secures Sharpe Ratio (or Efficiency) of 0.18, which signifies that the company had a 0.18% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Bristol Myers Squibb, which you can use to evaluate the volatility of the firm. Please makes use of Bristol Myers' Downside Deviation of 1.49, mean deviation of 1.31, and Risk Adjusted Performance of 0.1454 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Bristol Myers holds a performance score of 13. The firm shows a Beta (market volatility) of 0.11, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Bristol Myers' returns are expected to increase less than the market. However, during the bear market, the loss of holding Bristol Myers is expected to be smaller as well. Please check Bristol Myers' sortino ratio, as well as the relationship between the semi variance and rate of daily change , to make a quick decision on whether Bristol Myers' price patterns will revert.
Auto-correlation | -0.15 |
Insignificant reverse predictability
Bristol Myers Squibb has insignificant reverse predictability. Overlapping area represents the amount of predictability between Bristol Myers time series from 26th of October 2024 to 10th of November 2024 and 10th of November 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bristol Myers Squibb price movement. The serial correlation of -0.15 indicates that less than 15.0% of current Bristol Myers price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.15 | |
| Spearman Rank Test | -0.46 | |
| Residual Average | 0.0 | |
| Price Variance | 0.92 |
Bristol Myers Squibb lagged returns against current returns
Autocorrelation, which is Bristol Myers stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Bristol Myers' stock expected returns. We can calculate the autocorrelation of Bristol Myers returns to help us make a trade decision. For example, suppose you find that Bristol Myers has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Bristol Myers regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Bristol Myers stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Bristol Myers stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Bristol Myers stock over time.
Current vs Lagged Prices |
| Timeline |
Bristol Myers Lagged Returns
When evaluating Bristol Myers' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Bristol Myers stock have on its future price. Bristol Myers autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Bristol Myers autocorrelation shows the relationship between Bristol Myers stock current value and its past values and can show if there is a momentum factor associated with investing in Bristol Myers Squibb.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Bristol Stock Analysis
When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.